Justin Call
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 22
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 3
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- D. Ross Camidge (4 shared papers)Sabine Eckhardt (2 shared papers)Carolina Escobar (1 shared paper)Swaminathan P. Iyer (1 shared paper)Daniel O. Persky (3 shared papers)Radhakrishnan Ramchandren (1 shared paper)William J. Edenfield (3 shared papers)Li Zhou (3 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Annals of Oncology (5 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Justin Call
33 papers receiving 335 citations
Peers
Comparison fields: 5 of 65
- Oncology 158
- Genetics 57
- Toxicology 15
- Immunology 82
- Pathology and Forensic Medicine 61
Countries citing papers authored by Justin Call
This map shows the geographic impact of Justin Call's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Call with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Call more than expected).
Fields of papers citing papers by Justin Call
This network shows the impact of papers produced by Justin Call. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Call. The network helps show where Justin Call may publish in the future.
Co-authors
The 25 scholars most cited alongside Justin Call, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 137 | |
| 2 | 2019 | 81 | |
| 3 | 2024 | 22 | |
| 4 | 2017 | 10 | |
| 5 | 2021 | 10 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 5 | |
| 10 | 2025 | 5 | |
| 11 | 2024 | 5 | |
| 12 | 2008 | 5 | |
| 13 | 2022 | 4 | |
| 14 | A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors and lymphoma | 2007 | 3 |
| 15 | 2023 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2017 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Justin Call
Justin Call is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 343 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (158 citations), Genetics (57 citations), Toxicology (15 citations), Immunology (82 citations) and Pathology and Forensic Medicine (61 citations). Justin Call has collaborated with scholars based in United States, Spain and France. Frequent co-authors include D. Ross Camidge, Sabine Eckhardt, Carolina Escobar, Swaminathan P. Iyer, Daniel O. Persky, Radhakrishnan Ramchandren, William J. Edenfield, Li Zhou, Fitzroy W. Dawkins and Paolo F. Caimi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Molecular Cancer Therapeutics and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.